한글목차

양막 제품 시장

양막 제품 시장은 2023년에 9억 달러로 평가되었으며, 2024-2033년 연평균 복합 성장률(CAGR) 6.9%로 성장하여 2033년에는 18억 달러에 이를 것으로 예측됩니다.

양막과 태반액을 포함한 양막 제품은 시토킨, 성장 인자, 세포 외 매트릭스 성분의 존재로 인해 재생 의료에 필수적인 성분입니다. 양막 제품은 조직 수복 촉진, 염증 완화, 흉터 예방에 유용하며 이식편, 패치, 주사, 외용액의 형태로 사용할 수 있습니다. 양막 제품의 작용은 세포의 이동, 증식 및 분화를 촉진하는 생물학적 활성 분자의 전달을 포함하여 치유를 촉진하고 염증을 완화합니다.

조직 공학의 진보로 양막 제품의 생리 활성을 유지하기위한 혁신적인 기술이 개발되었습니다. 이러한 기술 혁신이 양막 제품 시장의 주요 촉진요인이 되고 있습니다. 게다가 줄기세포 치료나 재생의료에 대한 기호의 고조가 조직의 재생·수복을 촉진하는 양막 제품의 채용을 뒷받침하고 있습니다. 조직 공학에서 양막 제품의 이용을 확대하기 위해 일렉트로 스피닝이나 적층제조 기술의 이용이 견인 역할을 하고 있습니다. 이러한 기술은 신경 재생과 같은 여러 임상 응용에 사용되는 새로운 다층 복합 기반 양막의 개발에 도움이 됩니다.

양막는 FDA에 의한 공중위생법 351조에 해당합니다. 그러나 미국 식품의약품협회(FDA)와 같은 정부기관과 연방기관이 부과하는 규제 준수에 대한 비싸고 시간이 많이 걸리는 경로 때문에 양막제품 시장의 개발 상황은 매우 엄격합니다. 따라서 양막제품의 사용 및 판매에는 승인된 생물제제 허가 신청이 필요합니다. 라이선스가 없는 경우 무거운 처벌이나 처벌의 대상이 됩니다.

부문 검토

양막 제품 시장은 제품, 용도, 최종 사용자, 지역으로 구분됩니다. 제품 기반에서 시장은 동결보존 양막과 동결 건조 양막으로 이분됩니다. 용도별로는 수술창, 안과, 정형외과 등으로 분류됩니다. 최종 사용자별로는 병원, 외래수술센터(ASC), 전문 클리닉, 연구센터 및 실험실로 나눌 수 있습니다. 지역별로는 북미, 유럽, 아시아태평양, LAMEA에서 분석됩니다.

주요 조사 결과

제품별로는 동결보존 양막분야가 높은 시장 점유율을 차지하고 있습니다.

용도별로는 수술창분야가 높은 점유율을 차지하고 있습니다.

최종 사용자별로는 병원 분야가 높은 점유율을 차지하고 있습니다.

지역별로는 북미가 양막 제품 시장에서 가장 높은 수익을 올리고 있습니다.

이 보고서에서 가능한 맞춤설정(추가 비용 및 일정이 있습니다.)

• 규제 가이드라인
• 고객의 관심에 따른 추가 기업 프로파일
• 과거 시장 데이터
• 수출입 분석/데이터
• 상환 시나리오

목차

제1장 서론

제2장 주요 요약

제3장 시장 상황

• 시장 정의와 범위
• 주요 조사 결과
  • 주요 투자 기회
  • 주요 성공 전략
• Porter's Five Forces 분석
• 시장 역학
  • 성장 촉진요인
  • 억제요인
  • 기회

제4장 아미오틱 제품 시장 : 제품별

• 시장 개요
• 동결보존 양막
• 동결건조 양막

제5장 양막제품 시장 : 용도별

• 시장 개요
• 수술창
• 안과
• 정형외과
• 기타

제6장 양막 제품 시장 : 최종 사용자별

• 시장 개요
• 병원
• 외래수술센터(ASC)
• 전문 클리닉
• 연구센터 연구소

제7장 양막 제품 시장 : 지역별

• 시장 개요
• 북미
  • 주요 시장 동향과 기회
  • 미국 양막 제품 시장
  • 캐나다 양막 제품 시장
  • 멕시코 양막 제품 시장
• 유럽
  • 주요 시장 동향과 기회
  • 프랑스 양막 제품 시장
  • 독일 양막 제품 시장
  • 이탈리아 양막 제품 시장
  • 스페인 양막 제품 시장
  • 영국 양막 제품 시장
  • 기타 유럽 양막 제품 시장
• 아시아태평양
  • 주요 시장 동향과 기회
  • 중국 양막 제품 시장
  • 일본 양막 제품 시장
  • 인도 양막 제품 시장
  • 한국 양막 제품 시장
  • 호주 양막 제품 시장
  • 기타 아시아태평양 양막 제품 시장
• 라틴아메리카, 중동 및 아프리카
  • 주요 시장 동향과 기회
  • 브라질 양막 제품 시장
  • 남아프리카 양막 제품 시장
  • 사우디아라비아 양막 제품 시장
  • 기타 라틴아메리카, 중동 및 아프리카 양막 제품 시장

제8장 경쟁 구도

• 소개
• 주요 성공 전략
• 주요 10기업의 제품 매핑
• 경쟁 대시보드
• 경쟁 히트맵
• 주요 기업의 포지셔닝(2023년)

제9장 기업 프로파일

• Allosure, Inc.
• Amnio Technology, LLC
• Applied Biologics LLC
• FzioMed, Inc.
• Human Regenerative Technologies, LLC
• Integra Lifesciences Holdings Corporation
• Corza Ophthalmology
• MiMedx Group, Inc.
• Skye Biologics Inc.
• Tissue-Tech, Inc.

영문목차

Amniotic Product Market

The amniotic product market was valued at $0.9 billion in 2023 and is projected to reach $1.8 billion by 2033, growing at a CAGR of 6.9% from 2024 to 2033.

Amniotic product, including amniotic membrane and fluid of the placenta, is an essential component of regenerative medicine due to the presence of cytokines, growth factors, and extracellular matrix components. The products are useful in the promotion of tissue repair, reduction of inflammation, & scar prevention and are available in the form of grafts, patches, injections, and topical solutions. The working of amniotic products includes the delivery of bioactive molecules to enhance cellular migration, proliferation, and differentiation, which results in accelerated healing & reduced inflammation.

Advancements in tissue engineering have led to the development of innovative techniques for preserving the bioactivity of amniotic products. These innovations are a key driver of the amniotic product market. In addition, surge in preference for stem cell therapies and regenerative medicine is boosting the adoption of amniotic products, as they promote tissue regeneration and repair. To expand the usage of amniotic products in tissue engineering, the usage of electrospinning and additive manufacturing technologies is acquiring traction. These technologies help in the development of novel multilayer composite-based amniotic membranes which are utilized for several clinical applications such as nerve regeneration.

However, the development landscape for the amniotic product market is highly challenging due to the expensive and time-consuming pathway regarding compliance with the regulations imposed by the government or federal agencies such as the Food and Drug Association (FDA) in the U.S. Amniotic fluid falls under Section 351 of the Public Health Service Act by the FDA. Hence, usage and marketing of the amniotic products require an approved Biologics License Application. The case of non-availability of the license leads to heavy penalties and punishment.

Segment Review

The amniotic product market is segmented into product, application, end user, and region. On the basis of product, the market is bifurcated into cryopreserved amniotic and lyophilization amniotic. As per application, it is classified into surgical wounds, ophthalmology, orthopedic, and others. By end user, it is divided into hospitals, ambulatory surgical centers, specialized clinics, and research centers & laboratory. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of product, the cryopreserved amniotic segment accounts for a high market share.

As per application, the surgical wounds segment acquires a high stake in the market.

By end user, the hospitals segment holds a high share in the market.

Region wise, North America generates the highest revenue in the amniotic product market.

Competition Analysis

The leading players operating in the global amniotic product market include Allosure, Inc., Amnio Technology, LLC, applied biologics llc, FzioMed, Inc., Human Regenerative Technologies, LLC, Integra Lifesciences Holdings Corporation, Corza Ophthalmology, MiMedx Group, Inc., Skye Biologics Inc., and Tissue-Tech, Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• Regulatory Guidelines
• Additional company profiles with specific to client's interest
• Historic market data
• Import Export Analysis/Data
• Reimbursement Scenario

Key Market Segments

By Product

• Cryopreserved Amniotic
• Lyophilization Amniotic

By Application

• Surgical Wounds
• Ophthalmology
• Orthopedic
• Others

By End User

• Hospitals
• Ambulatory Surgical Centers
• Specialized Clinics
• Research Centers Laboratory

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • Italy
  • Spain
  • UK
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • South Africa
  • Saudi Arabia
  • Rest of LAMEA

Key Market Players:

• Allosure, Inc.
• Amnio Technology, LLC
• applied biologics llc
• FzioMed, Inc.
• Human Regenerative Technologies, LLC
• Integra Lifesciences Holdings Corporation
• Corza Ophthalmology
• MiMedx Group, Inc.
• Skye Biologics Inc.
• Tissue-Tech, Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report Description
• 1.2. Key Market Segments
• 1.3. Key Benefits
• 1.4. Research Methodology
  • 1.4.1. Primary Research
  • 1.4.2. Secondary Research
  • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

• 3.1. Market Definition and Scope
• 3.2. Key Findings
  • 3.2.1. Top Investment Pockets
  • 3.2.2. Top Winning Strategies
• 3.3. Porter's Five Forces Analysis
  • 3.3.1. Bargaining Power of Suppliers
  • 3.3.2. Threat of New Entrants
  • 3.3.3. Threat of Substitutes
  • 3.3.4. Competitive Rivalry
  • 3.3.5. Bargaining Power among Buyers
• 3.4. Market Dynamics
  • 3.4.1. Drivers
  • 3.4.2. Restraints
  • 3.4.3. Opportunities

CHAPTER 4: AMNIOTIC PRODUCT MARKET, BY PRODUCT

• 4.1. Market Overview
  • 4.1.1 Market Size and Forecast, By Product
• 4.2. Cryopreserved Amniotic
  • 4.2.1. Key Market Trends, Growth Factors and Opportunities
  • 4.2.2. Market Size and Forecast, By Region
  • 4.2.3. Market Share Analysis, By Country
• 4.3. Lyophilization Amniotic
  • 4.3.1. Key Market Trends, Growth Factors and Opportunities
  • 4.3.2. Market Size and Forecast, By Region
  • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: AMNIOTIC PRODUCT MARKET, BY APPLICATION

• 5.1. Market Overview
  • 5.1.1 Market Size and Forecast, By Application
• 5.2. Surgical Wounds
  • 5.2.1. Key Market Trends, Growth Factors and Opportunities
  • 5.2.2. Market Size and Forecast, By Region
  • 5.2.3. Market Share Analysis, By Country
• 5.3. Ophthalmology
  • 5.3.1. Key Market Trends, Growth Factors and Opportunities
  • 5.3.2. Market Size and Forecast, By Region
  • 5.3.3. Market Share Analysis, By Country
• 5.4. Orthopedic
  • 5.4.1. Key Market Trends, Growth Factors and Opportunities
  • 5.4.2. Market Size and Forecast, By Region
  • 5.4.3. Market Share Analysis, By Country
• 5.5. Others
  • 5.5.1. Key Market Trends, Growth Factors and Opportunities
  • 5.5.2. Market Size and Forecast, By Region
  • 5.5.3. Market Share Analysis, By Country

CHAPTER 6: AMNIOTIC PRODUCT MARKET, BY END USER

• 6.1. Market Overview
  • 6.1.1 Market Size and Forecast, By End User
• 6.2. Hospitals
  • 6.2.1. Key Market Trends, Growth Factors and Opportunities
  • 6.2.2. Market Size and Forecast, By Region
  • 6.2.3. Market Share Analysis, By Country
• 6.3. Ambulatory Surgical Centers
  • 6.3.1. Key Market Trends, Growth Factors and Opportunities
  • 6.3.2. Market Size and Forecast, By Region
  • 6.3.3. Market Share Analysis, By Country
• 6.4. Specialized Clinics
  • 6.4.1. Key Market Trends, Growth Factors and Opportunities
  • 6.4.2. Market Size and Forecast, By Region
  • 6.4.3. Market Share Analysis, By Country
• 6.5. Research Centers Laboratory
  • 6.5.1. Key Market Trends, Growth Factors and Opportunities
  • 6.5.2. Market Size and Forecast, By Region
  • 6.5.3. Market Share Analysis, By Country

CHAPTER 7: AMNIOTIC PRODUCT MARKET, BY REGION

• 7.1. Market Overview
  • 7.1.1 Market Size and Forecast, By Region
• 7.2. North America
  • 7.2.1. Key Market Trends and Opportunities
  • 7.2.2. Market Size and Forecast, By Product
  • 7.2.3. Market Size and Forecast, By Application
  • 7.2.4. Market Size and Forecast, By End User
  • 7.2.5. Market Size and Forecast, By Country
  • 7.2.6. U.S. Amniotic Product Market
    • 7.2.6.1. Market Size and Forecast, By Product
    • 7.2.6.2. Market Size and Forecast, By Application
    • 7.2.6.3. Market Size and Forecast, By End User
  • 7.2.7. Canada Amniotic Product Market
    • 7.2.7.1. Market Size and Forecast, By Product
    • 7.2.7.2. Market Size and Forecast, By Application
    • 7.2.7.3. Market Size and Forecast, By End User
  • 7.2.8. Mexico Amniotic Product Market
    • 7.2.8.1. Market Size and Forecast, By Product
    • 7.2.8.2. Market Size and Forecast, By Application
    • 7.2.8.3. Market Size and Forecast, By End User
• 7.3. Europe
  • 7.3.1. Key Market Trends and Opportunities
  • 7.3.2. Market Size and Forecast, By Product
  • 7.3.3. Market Size and Forecast, By Application
  • 7.3.4. Market Size and Forecast, By End User
  • 7.3.5. Market Size and Forecast, By Country
  • 7.3.6. France Amniotic Product Market
    • 7.3.6.1. Market Size and Forecast, By Product
    • 7.3.6.2. Market Size and Forecast, By Application
    • 7.3.6.3. Market Size and Forecast, By End User
  • 7.3.7. Germany Amniotic Product Market
    • 7.3.7.1. Market Size and Forecast, By Product
    • 7.3.7.2. Market Size and Forecast, By Application
    • 7.3.7.3. Market Size and Forecast, By End User
  • 7.3.8. Italy Amniotic Product Market
    • 7.3.8.1. Market Size and Forecast, By Product
    • 7.3.8.2. Market Size and Forecast, By Application
    • 7.3.8.3. Market Size and Forecast, By End User
  • 7.3.9. Spain Amniotic Product Market
    • 7.3.9.1. Market Size and Forecast, By Product
    • 7.3.9.2. Market Size and Forecast, By Application
    • 7.3.9.3. Market Size and Forecast, By End User
  • 7.3.10. UK Amniotic Product Market
    • 7.3.10.1. Market Size and Forecast, By Product
    • 7.3.10.2. Market Size and Forecast, By Application
    • 7.3.10.3. Market Size and Forecast, By End User
  • 7.3.11. Rest of Europe Amniotic Product Market
    • 7.3.11.1. Market Size and Forecast, By Product
    • 7.3.11.2. Market Size and Forecast, By Application
    • 7.3.11.3. Market Size and Forecast, By End User
• 7.4. Asia-Pacific
  • 7.4.1. Key Market Trends and Opportunities
  • 7.4.2. Market Size and Forecast, By Product
  • 7.4.3. Market Size and Forecast, By Application
  • 7.4.4. Market Size and Forecast, By End User
  • 7.4.5. Market Size and Forecast, By Country
  • 7.4.6. China Amniotic Product Market
    • 7.4.6.1. Market Size and Forecast, By Product
    • 7.4.6.2. Market Size and Forecast, By Application
    • 7.4.6.3. Market Size and Forecast, By End User
  • 7.4.7. Japan Amniotic Product Market
    • 7.4.7.1. Market Size and Forecast, By Product
    • 7.4.7.2. Market Size and Forecast, By Application
    • 7.4.7.3. Market Size and Forecast, By End User
  • 7.4.8. India Amniotic Product Market
    • 7.4.8.1. Market Size and Forecast, By Product
    • 7.4.8.2. Market Size and Forecast, By Application
    • 7.4.8.3. Market Size and Forecast, By End User
  • 7.4.9. South Korea Amniotic Product Market
    • 7.4.9.1. Market Size and Forecast, By Product
    • 7.4.9.2. Market Size and Forecast, By Application
    • 7.4.9.3. Market Size and Forecast, By End User
  • 7.4.10. Australia Amniotic Product Market
    • 7.4.10.1. Market Size and Forecast, By Product
    • 7.4.10.2. Market Size and Forecast, By Application
    • 7.4.10.3. Market Size and Forecast, By End User
  • 7.4.11. Rest of Asia-Pacific Amniotic Product Market
    • 7.4.11.1. Market Size and Forecast, By Product
    • 7.4.11.2. Market Size and Forecast, By Application
    • 7.4.11.3. Market Size and Forecast, By End User
• 7.5. LAMEA
  • 7.5.1. Key Market Trends and Opportunities
  • 7.5.2. Market Size and Forecast, By Product
  • 7.5.3. Market Size and Forecast, By Application
  • 7.5.4. Market Size and Forecast, By End User
  • 7.5.5. Market Size and Forecast, By Country
  • 7.5.6. Brazil Amniotic Product Market
    • 7.5.6.1. Market Size and Forecast, By Product
    • 7.5.6.2. Market Size and Forecast, By Application
    • 7.5.6.3. Market Size and Forecast, By End User
  • 7.5.7. South Africa Amniotic Product Market
    • 7.5.7.1. Market Size and Forecast, By Product
    • 7.5.7.2. Market Size and Forecast, By Application
    • 7.5.7.3. Market Size and Forecast, By End User
  • 7.5.8. Saudi Arabia Amniotic Product Market
    • 7.5.8.1. Market Size and Forecast, By Product
    • 7.5.8.2. Market Size and Forecast, By Application
    • 7.5.8.3. Market Size and Forecast, By End User
  • 7.5.9. Rest of LAMEA Amniotic Product Market
    • 7.5.9.1. Market Size and Forecast, By Product
    • 7.5.9.2. Market Size and Forecast, By Application
    • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

• 8.1. Introduction
• 8.2. Top Winning Strategies
• 8.3. Product Mapping of Top 10 Player
• 8.4. Competitive Dashboard
• 8.5. Competitive Heatmap
• 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

• 9.1. Allosure, Inc.
  • 9.1.1. Company Overview
  • 9.1.2. Key Executives
  • 9.1.3. Company Snapshot
  • 9.1.4. Operating Business Segments
  • 9.1.5. Product Portfolio
  • 9.1.6. Business Performance
  • 9.1.7. Key Strategic Moves and Developments
• 9.2. Amnio Technology, LLC
  • 9.2.1. Company Overview
  • 9.2.2. Key Executives
  • 9.2.3. Company Snapshot
  • 9.2.4. Operating Business Segments
  • 9.2.5. Product Portfolio
  • 9.2.6. Business Performance
  • 9.2.7. Key Strategic Moves and Developments
• 9.3. Applied Biologics LLC
  • 9.3.1. Company Overview
  • 9.3.2. Key Executives
  • 9.3.3. Company Snapshot
  • 9.3.4. Operating Business Segments
  • 9.3.5. Product Portfolio
  • 9.3.6. Business Performance
  • 9.3.7. Key Strategic Moves and Developments
• 9.4. FzioMed, Inc.
  • 9.4.1. Company Overview
  • 9.4.2. Key Executives
  • 9.4.3. Company Snapshot
  • 9.4.4. Operating Business Segments
  • 9.4.5. Product Portfolio
  • 9.4.6. Business Performance
  • 9.4.7. Key Strategic Moves and Developments
• 9.5. Human Regenerative Technologies, LLC
  • 9.5.1. Company Overview
  • 9.5.2. Key Executives
  • 9.5.3. Company Snapshot
  • 9.5.4. Operating Business Segments
  • 9.5.5. Product Portfolio
  • 9.5.6. Business Performance
  • 9.5.7. Key Strategic Moves and Developments
• 9.6. Integra Lifesciences Holdings Corporation
  • 9.6.1. Company Overview
  • 9.6.2. Key Executives
  • 9.6.3. Company Snapshot
  • 9.6.4. Operating Business Segments
  • 9.6.5. Product Portfolio
  • 9.6.6. Business Performance
  • 9.6.7. Key Strategic Moves and Developments
• 9.7. Corza Ophthalmology
  • 9.7.1. Company Overview
  • 9.7.2. Key Executives
  • 9.7.3. Company Snapshot
  • 9.7.4. Operating Business Segments
  • 9.7.5. Product Portfolio
  • 9.7.6. Business Performance
  • 9.7.7. Key Strategic Moves and Developments
• 9.8. MiMedx Group, Inc.
  • 9.8.1. Company Overview
  • 9.8.2. Key Executives
  • 9.8.3. Company Snapshot
  • 9.8.4. Operating Business Segments
  • 9.8.5. Product Portfolio
  • 9.8.6. Business Performance
  • 9.8.7. Key Strategic Moves and Developments
• 9.9. Skye Biologics Inc.
  • 9.9.1. Company Overview
  • 9.9.2. Key Executives
  • 9.9.3. Company Snapshot
  • 9.9.4. Operating Business Segments
  • 9.9.5. Product Portfolio
  • 9.9.6. Business Performance
  • 9.9.7. Key Strategic Moves and Developments
• 9.10. Tissue-Tech, Inc.
  • 9.10.1. Company Overview
  • 9.10.2. Key Executives
  • 9.10.3. Company Snapshot
  • 9.10.4. Operating Business Segments
  • 9.10.5. Product Portfolio
  • 9.10.6. Business Performance
  • 9.10.7. Key Strategic Moves and Developments